Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials. by Charles Ferte, Jean-Charles Soria, Nicolas Penel

Get full text

Predictive value of clinical judgment of tumour progression in phase II trials. by Nuria Kotecki, Nicolas Penel, Antoine Adenis, Charles Ferte, Stéphanie Clisant

Get full text

Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study by Simon Nannini, Nicolas Penel, Emmanuelle Bompas, Thibault Willaume, Jean-Emmanuel Kurtz, Justine Gantzer

Get full text

Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer by Alexander Spira, Alexander Spira, Ahmad Awada, Nicolas Isambert, David Lorente, Nicolas Penel, Nicolas Penel, Yue Zhang, Laureen S. Ojalvo, Christine Hicking, P. Alexander Rolfe, Christian Ihling, Isabelle Dussault, George Locke, Christian Borel

Get full text

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer by Pauline Parent, Gautier Marcq, Sola Adeleke, Anthony Turpin, Stergios Boussios, Elie Rassy, Nicolas Penel

Get full text

Myositis ossificans circumscripta after surgery and radiotherapy and during sunitinib treatment: a case report by Pierre-Yves Cren, Nicolas Penel, Abel Cordoba, Gauthier Decanter, Louise Gaboriau, Mariem Ben Haj Amor

Get full text

Effect of medical staff training on vaccination coverage in outpatients with cancer: An interventional multicenter before-and-after study by Pierre Rivière, Nicolas Penel, Karine Faure, Guillaume Marie, Abeer Najem, Marie-Karelle Rivière, Sophie Panaget

Get full text

Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study by Côme De Metz, Benjamin Hennart, Estelle Aymes, Pierre‐Yves Cren, Niels Martignène, Nicolas Penel, Maël Barthoulot, Aurélien Carnot

Get full text

Midazolam sedation in palliative medicine: retrospective study in a French center for cancer control by Vincent Gamblin, Vincent Berry, Emmanuelle Tresch-Bruneel, Michel Reich, Arlette Da Silva, Stéphanie Villet, Nicolas Penel, Chloé Prod’Homme

Get full text

Is the survival of patients treated with ipilimumab affected by antibiotics? An analysis of 1585 patients from the French National hospital discharge summary database (PMSI) by Pierre-Yves Cren, Nicolas Bertrand, Marie-Cécile Le Deley, Michaël Génin, Laurent Mortier, Pascal Odou, Nicolas Penel, Emmanuel Chazard

Get full text

Development and validation of a bedside score to predict early death in cancer of unknown primary patients. by Nicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, Charles Ferte, Patrick Devos, Antoine Hollebecque, Michael B Sawyer, Antoine Adenis, Pascal Seve

Get full text

Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiat... by Noémie Huchet, Nicolas Penel, Sylvie Bonvalot, Juliette Thariat, Françoise Ducimetière, Antoine Giraud, Maud Toulmonde, Axel Le Cesne, Jean-Yves Blay, Carine Bellera

Get full text

A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment by Karthick Vishwanathan, Inmaculada Sanchez‐Simon, Bhumsuk Keam, Nicolas Penel, Maria deMiguel‐Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Martin Johnson, Alain Ravaud

Get full text

Home hospitalization for palliative cancer care: factors associated with unplanned hospital admissions and death in hospital by Vincent Gamblin, Chloé Prod’homme, Adrien Lecoeuvre, André -Michel Bimbai, Joël Luu, Pierre-Alexandre Hazard, Arlette Da Silva, Stéphanie Villet, Marie-Cécile Le Deley, Nicolas Penel

Get full text

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study by Thomas Brodowicz, Bernadette Liegl-Atzwanger, Nicolas Penel, Olivier Mir, Jean-Yves Blay, Karl Kashofer, Axel Le Cesne, Emilie Decoupigny, Jennifer Wallet, Rainer Hamacher, Marie-Cecile Le Deley

Get full text

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial by Diane Pannier, Antoine Adenis, Emilie Bogart, Eric Dansin, Stéphanie Clisant-Delaine, Emilie Decoupigny, Anne Lesoin, Eric Amela, Sandrine Ducornet, Jean-Pierre Meurant, Marie-Cécile Le Deley, Nicolas Penel

Get full text

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison by Nicolas Penel, Coralie Cantarel, Claire Chemin-Airiau, Françoise Ducimetiere, François Gouin, François Le Loarer, Maud Toulmonde, Sophie Piperno-Neumann, Carine Bellera, Charles Honore, Jean-Yves Blay, Simone Mathoulin-Pelissier

Get full text

The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer by François Cherifi, François Cherifi, Sophie Lefevre Arbogast, Sophie Lefevre Arbogast, Jonaz Font, Cyril Abdeddaim, Stephanie Becourt, Nicolas Penel, Elodie Coquan, Elodie Coquan, Justine Lequesne, Yori Gidron, Florence Joly, Florence Joly

Get full text

Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM) by Brice Amadeo, Nicolas Penel, Jean-Michel Coindre, Isabelle Ray-Coquard, Karine Ligier, Patricia Delafosse, Anne-Marie Bouvier, Sandrine Plouvier, Justine Gallet, Aude Lacourt, Gaëlle Coureau, Alain Monnereau, Simone Mathoulin-Pélissier, Emmanuel Desandes

Get full text

ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy by Hendrik-Tobias Arkenau, Jean-Yves Douillard, Nicolas Penel, Teresa Amaral, Ahmad Awada, Emiliano Calvo, Viktor Gruenwald, Jose Luis Perez-Gracia, Ruth Vera, Martijn P Lolkema, Gyorgy Bodoky, Massimo Di Nicola, Miguel F Sanmamed

Get full text